Medication-info.com Search Menu

Ipratropium Inhalation: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
0.5 mg/2.5 mL
Brand names:
Drug class:
Active ingredient:

Patient information: uses, side effects, how to take - Ipratropium Inhalation

Patient's Instructions for Use

Ipatropium Bromide Inhalational Solution, USP 0.02%

Read complete instructions carefully before using.

  1. 1.

    Twist open the top of one unit-dose vial and squeeze the contents into the nebulizer reservoir (Figure 1).

    Figure 1

  2. 2.

    Connect the nebulizer reservoir to the mouthpiece or face mask (Figure 2).

    Figure 2

  3. 3.

    Connect the nebulizer to the compressor.

    Figure 3

  4. 4. Sit in a comfortable, upright position; place the mouthpiece in your mouth (Figure 3) or put on the face mask and turn on the compressor. If a face mask is used, care should be taken to avoid leakage around the mask as temporary blurring of vision, pupil enlargement, precipitation or worsening of narrow-angle glaucoma, or eye pain may occur if the solution comes into direct contact with the eyes.
  5. 5. Breathe as calmly, deeply and evenly as possible until no more mist is formed in the nebulizer chamber (about 5-10 minutes). At this point, the treatment is finished.
  6. 6. Clean the nebulizer (see manufacturer’s instructions).

Note: Use only as directed by your physician. More frequent administration or higher doses are not recommended. Ipratropium bromide inhalation solution can be mixed in the nebulizer with albuterol or metaproterenol if used within one hour but not with other drugs. Drug stability and safety of ipratropium bromide inhalation solution when mixed with other drugs in a nebulizer have not been established.

Store between 15° C and 30° C (59° F and 86° F).

Protect from light.

Store unused vials in the foil pouch.

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: ANDA 075562 · View the label on DailyMed

Revision date stated in the text: July 2024

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Ipratropium Inhalation

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Anticholinergic
Active ingredient Ipratropium bromide 0.5 mg/2.5 mL
Dosage form Solution
Route Respiratory (inhalation)
Marketing status listed in the FDA NDC Directory
Company (applicant) NEPHRON
FDA approval ANDA 075562Abbreviated New Drug Application (ANDA) – generic drug Approved September 27, 2001
Therapeutic equivalence (TE) code ANCodes starting with A mean the FDA rates the drug therapeutically equivalent to its reference drug (Orange Book).
Manufacturers 10 labelers list this drug on DailyMed
Packages (NDC)
Package
0.5 mg/2.5 mL – 2.5 ml in 1 vial, single-dose / 25 in 1 pouch / 1 in 1 carton NDC 64980-640-02
0.5 mg/2.5 mL – 2.5 ml in 1 vial, single-dose / 30 in 1 pouch / 1 in 1 carton NDC 64980-640-03
0.5 mg/2.5 mL – 2.5 ml in 1 vial, single-dose / 30 in 1 pouch / 2 in 1 carton NDC 64980-640-06

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.